Tumor promoting effects of CD95 signaling in chemoresistant cells.
about
The role of CD95 and CD95 ligand in cancerRegulation of the metastatic cell phenotype by sialylated glycansIdentification of initial leads directed at the calmodulin-binding region on the Src-SH2 domain that exhibit anti-proliferation activity against pancreatic cancerNeutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro.Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK).
P2860
Tumor promoting effects of CD95 signaling in chemoresistant cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Tumor promoting effects of CD95 signaling in chemoresistant cells.
@en
Tumor promoting effects of CD95 signaling in chemoresistant cells.
@nl
type
label
Tumor promoting effects of CD95 signaling in chemoresistant cells.
@en
Tumor promoting effects of CD95 signaling in chemoresistant cells.
@nl
prefLabel
Tumor promoting effects of CD95 signaling in chemoresistant cells.
@en
Tumor promoting effects of CD95 signaling in chemoresistant cells.
@nl
P2093
P2860
P356
P1433
P1476
Tumor promoting effects of CD95 signaling in chemoresistant cells.
@en
P2093
Cristina Mayordomo
Domizziana Costamagna
Elisabet Ametller
Eva María Pastor-Arroyo
Neus Carbó
Patricia Fernández-Nogueira
Pedro Gascón
Susana García-Recio
Vanessa Almendro
P2860
P2888
P356
10.1186/1476-4598-9-161
P577
2010-06-23T00:00:00Z
P5875
P6179
1039426283